Table 3.
Correlation between SM1 excitability and metal variables.
| Healthy control | AD patients | |||
|---|---|---|---|---|
| M20 ECD strength | M30 ECD strength | M20 ECD strength | M30 ECD strength | |
| Copper | −.760 | .486 | −.010 | .071 |
| .011 | .222 | .973 | .826 | |
| Perox | −.823 | .058 | −.351 | −.338 |
| .003 | .891 | .239 | .282 | |
| Cerulopasmin | −.882 | .136 | −.463 | −.539 |
| .002 | .771 | .111 | .070 | |
| Transferrin | −.514 | .017 | −.461 | −.559 |
| .193 | .975 | .180 | .118 | |
| TAS | −.054 | .290 | −.043 | .059 |
| .890 | .528 | .888 | .855 | |
| Non-Cp copper | −.357 | .561 | .393 | .648 |
| .345 | .190 | .184 | .023 | |
Pearson's coefficient (upper row) and two-tail significance (lower row) of the correlation between the metal variables and the ECD strengths (expressed as nA∗m) of glutamate-mediated M20 and glutamate- and gaba-mediated M30 for controls and patients. Bold font is used when P < 0.05.